Evidence map›Paper›PMID 42222009›Full record

ArticleSynthetic biology (Oxford, England)2026

Chemically synthesized high-fidelity oligos ≤ 600 nt as building blocks to accelerate complex gene construction in synthetic biology.

Mancang Zhang, Yang Hu, Hao Huang, Yongyong Shi

Abstract read
In one paragraph

Article in Synthetic biology (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mancang ZhangBio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200030, People's Republic of China.ORCID https://orcid.org/0009-0002-2189-9257
Yang HuUnited Research Center for Next Generation DNA Synthesis of SJTU, Innovation Team, Shanghai 201108, People's Republic of China.
Hao HuangUnited Research Center for Next Generation DNA Synthesis of SJTU, Innovation Team, Shanghai 201108, People's Republic of China.
Yongyong ShiBio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200030, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synthetic biology and advanced genetic engineering applications rely heavily on the efficient construction of large and complex DNA sequences. Current DNA synthesis technologies have limited capacity to efficiently generate ultralong oligonucleotides for complex gene construction, particularly those with extensive repetitive motifs and uneven base distribution. Here, we report a novel platform named UCOS (Ultralong Complex Oligonucleotides Synthesis) that enables the efficient synthesis of long, complex, and challenging DNA fragments. This platform employs nonporous silica microspheres as the solid support instead of the traditional controlled pore glass solid support, full-length enrichment based on 5' flank sequence hybridization and an error-removing enzyme for correct sequence selection, substantially enhancing the fidelity of intricate, ultralong oligonucleotides. Using this approach, we successfully synthesized challenging sequences ≤600 nt in length, encompassing tandem repeats and uneven base distributions. Overall, this novel platform demonstrates exceptional efficiency and reliability in handling ultralong DNA fragments with highly repetitive and complex features. This novel platform provides a strong foundation for advancing synthetic biology and metabolic engineering, showing great potential as a powerful tool for constructing challenging genes and enabling the customized synthesis of functional genetic elements for complex genetic programmes and synthetic genomics.

Indexed as

chemical synthesiscomplex genessynthetic biological DNA partsultralong oligonucleotides

Identifiers

PMID42222009
PMCPMC13218287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.